We’re Bullish on Adobe Despite 40% Drop From Peak
Adobe has pulled back about 40% from its peak, but new AI-driven products and expanding ARR are reinvigorating the bu...
What Affects Stock Index Readings
What Affects Stock Index Readings covers key drivers behind index moves, including earnings, rates, and macro trends, helping you interpret the signals.
18,332 articlesPrice Prediction: Figma Will End the Year at This Price
Mid-year, Figma faces a volatile path as investors weigh AI-led growth against high valuation. A refreshed price pred...
Anthropic's Potential $1.2 Trillion IPO Could Boost Stock
As Anthropic eyes an IPO, a potential $1.2 trillion valuation could ripple through AI stocks. This piece breaks down ...
Neptune (NP) 2025 Earnings: Deep Dive and Investment Outlook
Navigate Neptune's Q4 2025 performance, understand margin dynamics, and gauge 2026 guidance. This practical guide exp...
Billionaire Activist Investors Just Shake Up Travel Stocks
Two major travel stocks have caught the eye of billionaire activist investors. This article breaks down what could ha...
Best Warren Buffett Stocks to Buy with $300 Right Now
You don't need a fortune to follow Warren Buffett's philosophy. With $300, you can start a durable, moat-rich lineup ...
China Holdings Sells Over: Yum China CEO Sells 100k Shares
When a top executive at Yum China sells a large block of stock, investors pay attention. This article breaks down the...
Buffett’s Stake Giving Investors Confidence in OXY Stock
Occidental Petroleum uses $9.7B from the OxyChem sale to trim debt, boosting cash flow and dividends. Berkshire Hatha...
This Much Berkshire Hathaway: Coca-Cola and AMEX Dividends 2025
Berkshire Hathaway’s long-running bets on Coca-Cola and American Express continue to pay off in 2025. This article br...
I've Changed Mind Microsoft: Why My Stock View Has Shifted
I’ve shifted my stance on MSFT stock as the AI era deepens, driven by Azure momentum, productivity platforms, and str...
Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Chipotle’s Stock Rebound From Slump Gaining Momentum
Chipotle’s stock rebound from a recent malaise is taking shape as pricing discipline and menu changes attract more di...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status